Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2025-10-24
DOI
https://doi.org/10.3389/fendo.2025.1699591
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial

Kensuke Ofuchi, Makoto Katoh, Nana Shiozawa, Mitsuru Hosoya et al.
Frontiers in Endocrinology
Diabetes Management and Research
article

Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial

Kensuke Ofuchi, Makoto Katoh, Nana Shiozawa, Mitsuru Hosoya, Satako Douguchi, Miyoko Saito, Takeshi Osonoi, Norie Watahiki, Shinichiro Shirabe
article en

Abstract

No abstract available for this paper.
Frontiers in EndocrinologyVol. 16
Kinan Hospital (JP), Saitama Medical University (JP)
Openalex Percentile: Top 58%
Diabetes Management and Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.